← Back to Search

FDG PET/MRI for Colorectal Cancer

N/A

Waitlist Available

Led By Tyler Fraum, M.D.

Research Sponsored by Washington University School of Medicine

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 12 months after completion of enrollment of all patients (26 months)

Awards & highlights

No Placebo-Only Group

Summary

This trial is testing if a PET/MRI can be used to monitor rectal cancer in patients who are not having surgery. The results will help design future clinical trials for this purpose.

Eligible Conditions

Rectal Cancer
Colorectal Cancer

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 12 months after completion of enrollment of all patients (26 months)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 12 months after completion of enrollment of all patients (26 months)

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 12 months after completion of enrollment of all patients (26 months) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Technical Feasibility of PET/MRI as Measured by the Completion of the Study With Acceptable Image Quality in ≥70% of Scans

Secondary study objectives

Percentage of Scans With Changes in Perceived Disease Status as Measured by PET/MRI Tumor Regression Grade Relative to the Conventional MRI Only Tumor Regression Grade

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: FDG PET/MRIExperimental Treatment1 Intervention

-Patients will undergo FDG-PET/MRI in lieu of the standard pelvic MRI at up to 6 time-points at which it would normally be performed in their care for the period of time extending 30-36 months from the time of enrollment (depending on enrollment point). In the surveillance period, when patients typically undergo pelvic MRI every 3 months, the FDG-PET/MRI will be done in lieu of the standard pelvic MRI on an approximately every-other-scan basis. In other words, the FDG-PET/MRI will occur roughly once every 6 months.

Do I qualify?Apply below to find out